FDA Approves Portola Drug Betrixaban For Blood Clot Prevention The Food and Drug Administration has approved betrixaban for preventing blood clotting among patients with deep vein thrombosis. The oral treatment is the first extended duration treatment for hospitalized acutely ill patients. by Alyssa Navarro
Health FDA Approves Rydapt For Treatment Of Acute Myeloid Leukemia In Adult Patients by Andrew Norman
Health Houston Officials Consider Use Of Genetically Modified Mosquitoes To Fight Zika Virus by Antonio Manaytay
Health Smokeless Tobacco Products Recalled As Sharp Metal Fragments Are Found Inside by Katrina Pascual
Health Prescription Testosterone, Other Steroid Drugs Product Labels Get New Warning From FDA by Carl Velasco
Health FDA Issues Safety Warning For St. Jude Medical Implanted Defibrillators After Two Deaths Reported by Livia Rusu
Health FDA Warns Against Hepatitis B Reactivation In Some Patients Taking Direct-Acting Hepatitis C Antivirals by Saranya Palanisamy
Health US Allows More Marijuana Research But Rejects Requests To Change Classification by Alyssa Navarro
Health Qsymia Dominates Among Weight Loss Drugs In Slashing 5 Percent Of Body Weight by Katrina Pascual
Health CDC Announces Listeria Outbreak Likely Caused By Frozen Fruits And Vegetables by Katrina Pascual
'Spray and Pray' iMessage Scam Haunts iPhone Owners: How to Avoid Losing Your Hard-Earned Money From it